help button home button
AJRCCM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Published ahead of print on November 1, 2007, doi:10.1164/rccm.200608-1190PP
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
200608-1190PPv1
177/4/369    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Related articles in AJRCCM
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gozal, D.
Right arrow Articles by Kheirandish-Gozal, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gozal, D.
Right arrow Articles by Kheirandish-Gozal, L.
American Journal of Respiratory and Critical Care Medicine Vol 177. pp. 369-375, (2008)
© 2008 American Thoracic Society
doi: 10.1164/rccm.200608-1190PP


Pulmonary Perspective

Cardiovascular Morbidity in Obstructive Sleep Apnea

Oxidative Stress, Inflammation, and Much More

David Gozal1 and Leila Kheirandish-Gozal1

1 Kosair Children's Hospital Research Institute, and Division of Pediatric Sleep Medicine, Department of Pediatrics, University of Louisville, Louisville, Kentucky

Correspondence and requests for reprints should be addressed to David Gozal, M.D., Kosair Children's Hospital Research Institute, University of Louisville School of Medicine, 570 South Preston Street, Suite 204, Louisville, KY 40202. E-mail: david.gozal{at}louisville.edu

ABSTRACT

Sleep-disordered breathing and obstructive sleep apnea (OSA) are highly prevalent disorders throughout the lifespan, which may affect up to 2–10% of the population, and have now been firmly associated with an increased risk for cardiovascular and neurobehavioral complications. Nevertheless, the overall pathophysiologic mechanisms mediating end-organ injury in OSA remain undefined, particularly due to the very frequent coexistence of other disease states, such as obesity, that clearly complicate the potential cause–effect relationships. Two major, and to some extent overlapping, mechanisms have been proposed to explain the morbid consequences of OSA, namely increased generation and propagation of reactive oxygen species and initiation and amplification of inflammatory processes. The evidence supporting the validity of these concepts as well as that detracting from such mechanisms will be critically reviewed in the context of clinical and laboratory-based approaches. In addition, some of the contradictory issues raised by such evaluation of the literature will be interpreted in the context of putative modifications of the individual responses to OSA, as determined by genetic variants among susceptibility-related genes, and also by potential environmental modulators of the phenotypic expression of any particular end-organ morbidity associated with OSA.

Key Words: inflammation • oxidative stress • reactive oxygen species • intermittent hypoxia • sleep fragmentation


Related articles in AJRCCM:

Respiratory Sleep Medicine: A Coming of Age
T. Douglas Bradley
AJRCCM 2008 177: 363-364. [Full Text]  



This article has been cited by other articles:


Home page
Am. J. Respir. Crit. Care Med.Home page
W. T. McNicholas
Chronic Obstructive Pulmonary Disease and Obstructive Sleep Apnea: Overlaps in Pathophysiology, Systemic Inflammation, and Cardiovascular Disease
Am. J. Respir. Crit. Care Med., October 15, 2009; 180(8): 692 - 700.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
R. L. Horner and T. D. Bradley
Update in Sleep and Control of Ventilation 2008
Am. J. Respir. Crit. Care Med., April 1, 2009; 179(7): 528 - 532.
[Full Text] [PDF]


Home page
Eur Respir JHome page
L. Ayers, B. Ferry, S. Craig, D. Nicoll, J. R. Stradling, and M. Kohler
Circulating cell-derived microparticles in patients with minimally symptomatic obstructive sleep apnoea
Eur. Respir. J., March 1, 2009; 33(3): 574 - 580.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
G. Lorenzi-Filho and L. F. Drager
Is the Cardiovascular System the Primary Target of Obstructive Sleep Apnea?
Am. J. Respir. Crit. Care Med., November 1, 2008; 178(9): 892 - 893.
[Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
M. Kohler, S. Craig, D. Nicoll, P. Leeson, R. J. O. Davies, and J. R. Stradling
Endothelial Function and Arterial Stiffness in Minimally Symptomatic Obstructive Sleep Apnea
Am. J. Respir. Crit. Care Med., November 1, 2008; 178(9): 984 - 988.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
T. D. Bradley
Respiratory Sleep Medicine: A Coming of Age
Am. J. Respir. Crit. Care Med., February 15, 2008; 177(4): 363 - 364.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Proc. Am. Thorac. Soc. Am. J. Respir. Cell Mol. Biol.
Copyright © 2008 American Thoracic Society
  New Orleans Int'l Conf